These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia. Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926 [TBL] [Abstract][Full Text] [Related]
24. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture. Ball ED; Keefe KA; McDermott JM Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116 [TBL] [Abstract][Full Text] [Related]
25. Immunomagnetic removal of CALLA positive cells from human bone marrow. Poynton CH; Dicke KA; Culbert S; Frankel LS; Jagannath S; Reading CL Lancet; 1983 Mar; 1(8323):524. PubMed ID: 6131225 [No Abstract] [Full Text] [Related]
26. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Ramsay N; LeBien T; Nesbit M; McGlave P; Weisdorf D; Kenyon P; Hurd D; Goldman A; Kim T; Kersey J Blood; 1985 Sep; 66(3):508-13. PubMed ID: 3896344 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies and bone marrow transplantation. Perticarari S; Presani G; Mangiarotti M; Andolina M Ric Clin Lab; 1984; 14(3):327-31. PubMed ID: 6395289 [No Abstract] [Full Text] [Related]
28. Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: analyses for two cases of failure. Ito T; Ishikawa Y; Noda M; Fujii R Jpn J Clin Oncol; 1987 Mar; 17(1):63-9. PubMed ID: 3031335 [TBL] [Abstract][Full Text] [Related]
29. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis. Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269 [TBL] [Abstract][Full Text] [Related]
30. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia. Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154 [TBL] [Abstract][Full Text] [Related]
31. Critical issues in autologous bone marrow transplantation in adult acute leukemia. Beran M; Zander AR Eur J Haematol; 1987 Aug; 39(2):97-117. PubMed ID: 3311797 [No Abstract] [Full Text] [Related]
32. Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood. Niemeyer CM; Ritz J; Donahue K; Sallan SE Haematol Blood Transfus; 1987; 31():67-74. PubMed ID: 2965082 [No Abstract] [Full Text] [Related]
33. Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia. Uckun FM; Gajl-Peczalska KJ; Kersey JH; Houston LL; Vallera DA J Exp Med; 1986 Feb; 163(2):347-68. PubMed ID: 3511171 [TBL] [Abstract][Full Text] [Related]
35. [Ex vivo purging methods for autologous bone marrow transplantation]. Kojima S; Ueda R Nihon Rinsho; 1990 Sep; 48(9):2117-24. PubMed ID: 2232217 [No Abstract] [Full Text] [Related]
36. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells. Howell AL; Fogg-Leach M; Davis BH; Ball ED Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117 [TBL] [Abstract][Full Text] [Related]
37. Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement. LeBien TW; Stepan DE; Bartholomew RM; Stong RC; Anderson JM Blood; 1985 Apr; 65(4):945-50. PubMed ID: 3884063 [TBL] [Abstract][Full Text] [Related]
38. Hematological parameters and marrow in vitro colony forming cells in acute lymphoblastic leukemia after cessation of treatment. Inoue S; Ravindranath Y; Lusher JM; Ito T Nihon Ketsueki Gakkai Zasshi; 1980 Feb; 43(1):61-70. PubMed ID: 6932156 [No Abstract] [Full Text] [Related]
39. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224 [TBL] [Abstract][Full Text] [Related]
40. Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia. Bradstock KF; Stevens M; Bergin M; Dalla-Pozza L; Duval P; Favaloro EJ; Kabral A; Kerr A; Juttner C; Zola H Aust N Z J Med; 1987 Jun; 17(3):283-9. PubMed ID: 2960307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]